Tag: Fabiflu

New Delhi: Glenmark Pharmaceuticals said on Tuesday that it has initiated phase – three clinical trials on antiviral Favipiravir for COVID-19 patients in India. COVID-19 patients from over 10 leading government and private hospitals in India are being enrolled for the study. The trial completion and study results are expected by July-August this year. Glenmark […]

New Delhi: In a strong rebuttal to the drug regulator, Glenmark Pharma said it has been at the receiving end of careless, unsubstantiated allegations that are devoid of merits related to Covid drug, Fabiflu. In a reply to V.G. Somani, Directorate General of Health Services, Central Drugs Standard Control Organisation, Glenmark has responded to allegations […]